Virdalis is a biotechnology company developing protein.
Virdalis has raised $700K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2026.
Virdalis's investors include Wavemaker Impact.
Virdalis is headquartered in Singapore, Singapore.
Virdalis is a biotechnology company developing protein.
Virdalis is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Virdalis — Funding & Investors." VCBacked, March 16, 2026, https://www.vcbacked.co/company/virdalis. Accessed August 15, 2026.
VCBacked. (2026). Virdalis — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/virdalis
{{cite web |title=Virdalis — Funding & Investors |url=https://www.vcbacked.co/company/virdalis |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated